Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLA-DR Antikörper

Der Maus Monoklonal anti-HLA-DR Antikörper wird verwendet zum Nachweis von HLA-DR in Proben von Human. Er wurde validiert für FACS und IF.
Produktnummer ABIN3026340
642,40 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für HLA-DR Antikörper (ABIN3026340)

Target

HLA-DR

Reaktivität

  • 179
  • 22
  • 19
  • 18
  • 18
  • 13
  • 11
  • 8
  • 6
  • 4
  • 2
  • 1
Human

Wirt

  • 136
  • 35
  • 10
  • 3
Maus

Klonalität

  • 176
  • 6
  • 1
Monoklonal

Konjugat

  • 78
  • 18
  • 17
  • 11
  • 9
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser HLA-DR Antikörper ist unkonjugiert

Applikation

  • 127
  • 52
  • 48
  • 25
  • 24
  • 16
  • 12
  • 10
  • 10
  • 10
  • 9
  • 5
  • 5
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF)

Güteklasse

Carrier-free

Klon

169-1B5-2
  • Verwendungszweck

    HLA-DR Antibody (MHC II) (azide and preservative free)

    Produktmerkmale

    This antibody detects a monomorphic general framework determinant of HLA-DR Class II antigen. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 Molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.

    Aufreinigung

    Protein G affinity chromatography

    Immunogen

    Human peripheral blood leukocytes were used as the immunogen for the HLA-DR antibody.

    Isotyp

    IgG2b, kappa
  • Applikationshinweise

    Optimal dilution of the HLA-DR antibody should be determined by the researcher.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Konservierungsmittel

    Azide free

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store the HLA-DR antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
  • Target

    HLA-DR

    Andere Bezeichnung

    HLA-DR

    Hintergrund

    This antibody detects a monomorphic general framework determinant of HLA-DR Class II antigen. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 Molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.

    UniProt

    P01903

    Pathways

    Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Sie sind hier:
Chat with us!